← All Sponsors
SPONSOR

Shanghai Qilu Pharmaceutical Research and Development Center LTD

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Atopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)

Clinical Trials by Shanghai Qilu Pharmaceutical Research and Development Center LTD

NCT06946641 Phase 1
Recruiting

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Atopic Dermatitis
China View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology